In an era of mega-rounds, Roivant Sciences still makes a splash with $1.1B haul
The top drug recycling engine in the game, Roivant Sciences, has raised a massive $1.1 billion equity investment round led by Softbank Vision Fund, with support from existing shareholders.
Announced Wednesday, the company said the new capital injection is designed to “accelerate the launch of new subsidiaries within and beyond the biopharmaceutical industry.”
That means expanding the Vant empire,…